Physician

Joseph Anthony Oommen, MD

According to 2025 Medicare claims, Joseph Oommen, MD (NPI: 1770518516) practices neurology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is JOSEPH A OOMMEN MD PLLC (NPI: 1568755544; TIN: 452273893) and primary practice location at 77706-3000.

Oommen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 22,310 HCPCS/CPT codes, and received $518,897 in Medicare payments. The top billing code was 99483 (Assessment of and care planning for patient with impaired thought processing, typically 60 minutes). Part D data shows 1,056 prescription claims across 379 beneficiaries totaling $1,060,158 in drug costs, led by Ingrezza (Valbenazine Tosylate). 2020 DME data shows 51 claims. Open Payments data shows 53 records totaling $1,056. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $183,779 to $518,897. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,042,124 and ending at $1,060,158. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,809 and ending at $2,814.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	627	7,558	$183,779
2016	568	10,793	$205,246
2017	513	8,848	$275,548
2018	495	7,776	$240,482
2019	610	7,498	$376,605
2020	556	9,830	$405,265
2021	472	7,938	$309,475
2022	426	19,108	$667,303
2023	428	31,759	$999,285
2024	385	22,310	$518,897

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	426	3,048	$1,042,124
2016	489	3,953	$1,590,136
2017	533	4,534	$1,965,167
2018	530	4,513	$2,028,313
2019	656	4,934	$1,579,179
2020	661	4,778	$2,001,569
2021	700	4,734	$1,489,326
2022	771	4,082	$1,245,612
2023	562	2,394	$1,182,001
2024	379	1,056	$1,060,158

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$517
2016	N/R	11	$79
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	51	$1,947
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99483	Assessment of and care planning for patient with impaired thought processing, typically 60 minutes	287	372	$209
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	291	595	$136
99211	Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional	116	134	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	330	730	$13
93040	Electrocardiogram (ecg) 1 to 3 leads with review by physician	104	107	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	49	1,455	$397,850
Gammaked	Immune Globul G/Gly/Iga Avg 46	27	567	$325,320
Epidiolex	Cannabidiol (Cbd)	11	378	$123,662
Zonisamide	Zonisamide	159	7,329	$3,085
Gabapentin	Gabapentin	133	6,011	$2,351

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,056	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph Anthony Oommen, MD?

Tedicare shows public-source Medicare data for Joseph Anthony Oommen, MD (NPI 1770518516), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Anthony Oommen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph Anthony Oommen, MD?

Joseph Anthony Oommen, MD is linked to JOSEPH A OOMMEN MD PLLC (billing NPI 1568755544) in the available physician profile data.

Does Joseph Anthony Oommen, MD have Open Payments data?

Joseph Anthony Oommen, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.